Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica.
Sánchez-Carteyron
Alejandro
A
Department of Neurology, Miguel Servet University Hospital, Isabel la Católica 1-3, 50009, Zaragoza, Spain. sanchezcarteyron@gmail.com
Alarcia
Raquel
R
Ara
José Ramón
JR
Martín
Jesús
J
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009471:Neuromyelitis Optica / Q000188:drug therapy* / Q000473:pathology; D020258:Neurotoxicity Syndromes / Q000473:pathology; D000069283:Rituximab; D013577:Syndrome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab